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Epithelial-mesenchymal interactions regulate normal gut epithelial homeostasis and have a putative role in
inflammatory bowel disease and colon cancer pathogenesis. Epimorphin is a mesenchymal and myofibroblast
protein with antiproliferative, promorphogenic effects in intestinal epithelium. We previously showed that
deletion of epimorphin partially protects mice from acute colitis, associated with an increase in crypt cell proliferation. Here we explored the potential therapeutic utility of modulating epimorphin expression by examining
the effects of epimorphin deletion on chronic inflammation–associated colon carcinogenesis using the azoxymethane/dextran sodium sulfate (AOM/DSS) model. We found that mice in which epimorphin expression was
absent had a marked reduction in incidence and extent of colonic dysplasia. Furthermore, epimorphin deletion in myofibroblasts altered the morphology and growth of cocultured epithelial cells. Loss of epimorphin
affected secretion of soluble mesenchymal regulators of the stem cell niche such as Chordin. Importantly, IL-6
secretion from LPS-treated epimorphin-deficient myofibroblasts was completely inhibited, and stromal IL-6
expression was reduced in vivo. Taken together, these data show that epimorphin deletion inhibits chronic
inflammation–associated colon carcinogenesis in mice, likely as a result of increased epithelial repair, decreased
myofibroblast IL-6 secretion, and diminished IL-6–induced inflammation. Furthermore, we believe that modulation of epimorphin expression may have therapeutic benefits in appropriate clinical settings.
*OUSPEVDUJPO
Dynamic and reciprocal epithelial-mesenchymal interactions play a
critical role in intestinal morphogenesis, maintenance of the steady
state between epithelial proliferation and differentiation along the
crypt villus axis (1), and epithelial carcinogenesis (2, 3). The gut
mesenchyme, which gives rise to subepithelial myofibroblasts as
well as other stromal components (4), supports the normal growth
and development of the endoderm and directs regional specificity in the gut (1, 5, 6). Mesenchymal stem cells (MSCs) likely play
an important role in epithelial injury and repair (7–9). Intestinal
subepithelial myofibroblasts are located in the lamina propria and
are directly adjacent to the crypts, which contain epithelial stem
and proliferating progenitor cells. Myofibroblasts secrete a variety
of signaling molecules, growth factors, and soluble mediators of
inflammation. These cells play a critical role in epithelial restitution
and wound repair and contribute to modulation of the immune
response, tissue fibrosis, and colonic tumorigenesis (3, 8, 10).
Epimorphin is a mesenchymal/myofibroblast protein that is a
member of the syntaxin family of membrane bound, intracellular
vesicle docking proteins known as t-SNAREs (11–13). Monomeric epimorphin (also referred to as syntaxin 2) has been detected
intracellularly as a component of the SNARE machinery that targets secretory vesicles to the plasma membrane (13, 14). Studies of
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lung, skin, and mammary epithelium suggest a role for myofibroblast/stromal epimorphin in the formation of luminal, ductular,
or branching structures during ontogeny (11, 15, 16). The molecular basis of the biologic function of epimorphin is complex, and
investigations of its role in morphogenesis of the mammary epithelium have suggested that epimorphin has distinct, cell-specific
extra- and intracellular roles (12, 16, 17).
We have previously shown that epimorphin is expressed by intestinal subepithelial myofibroblasts and that it exerts antiproliferative,
promorphogenetic effects on adjacent small intestinal epithelium
(18). To precisely define its in vivo role, we generated epimorphindeleted (Epim–/–) mice and showed that epimorphin regulates basal
proliferation of small intestinal, but not colonic, epithelium (19).
Neonatal Epim–/– mice have increased small bowel crypt depth,
crypt cell proliferation, and crypt fission. The consequences of epimorphin deletion are mediated, at least in part, by effects on bone
morphogenetic protein (BMP) and Wnt–β-catenin pathways (18,
19). Deletion of epimorphin partially protected the colon from
injury in a dextran sodium sulfate–induced (DSS-induced) colitis
model, associated with a marked increase in crypt cell proliferation
(19). These studies suggested that effects of epimorphin deletion
on downstream effector pathways may have potential therapeutic
benefit for human inflammatory bowel disease (IBD). A critical
complication of chronic gut inflammation from IBD is a markedly increased risk of colon cancer (20). To determine the long-term
effect of epimorphin deletion in colitis-associated colon cancer, here
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we examined the susceptibility of Epim–/– mice to chronic inflammation–induced carcinogenesis using the azoxymethane/DSS
(AOM/DSS) model. Epimorphin deletion resulted in an increase
in colonic crypt cell proliferation, yet markedly reduced dysplastic
tumor burden. Absence of epimorphin profoundly affected myofibroblast secretory function and response to LPS, resulting in
altered myofibroblast interactions with epithelium, in an in vitro
coculture model. In vivo analysis revealed decreased BMP signaling
and reduced IL-6 expression in AOM/DSS-treated Epim–/– colons.
Our results suggest that the myofibroblast plays an important role
in inflammation-induced colon cancer and that strategies to alter
myofibroblast function may provide novel therapeutic avenues for
the treatment of colitis and prevention of colitis-associated cancer.
3FTVMUT
Epimorphin deletion markedly reduces dysplasia and polyposis in the
AOM/DSS model of colon carcinogenesis. To determine the effects of
epimorphin deletion on inflammation-induced dysplasia and carcinogenesis, we treated congenic Epim–/– mice (C57BL/6J) and WT
C57BL/6J mice with AOM (13.5. mg/kg) followed by 3 5-day cycles
of 2.5%–3.0% DSS (Supplemental Figure 1; supplemental material
available online with this article; doi:10.1172/JCI40676DS1). This
regimen was chosen based on our pilot studies (see Methods) that
showed that lower doses of AOM and DSS (21, 22) were ineffective
in inducing dysplasia in WT and Epim–/– mice. The higher doses
resulted in dysplasia in 11 of 11 WT mice and 10 of 11 Epim–/–
mice, with a mortality rate of 50% (11 of 22) of WT mice and 35%
(6 of 17) of Epim–/– mice (P = NS).
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Induction of colitis in mice results in body weight loss. The percent body weight loss in Epim–/– mice was significantly reduced
compared with WT mice after the completion of the second of
3 DSS treatments (Supplemental Figure 2).
The pattern and extent of polyposis was evaluated in all mice
that survived the regimen (11 Epim–/– and 11 WT). Epim–/– mice
had a markedly decreased tumor load, with a decrease in the percentage of total colonic surface area grossly replaced by tumor,
compared with WT mice (WT, 14.45%; Epim–/–, 4.96%; P = 0.01;
Figure 1A). Whereas all WT mice had polyps and dysplasia, 1 of 11
Epim–/– mice had no evidence of polyps and dysplasia. Polyposis
in the WT mice was characterized grossly by multiple coalescing
tumors with very small areas of intervening normal mucosa. In
contrast, the Epim–/– polyposis phenotype consisted of scattered
lesions throughout the descending colon, separated by wide areas
of normal mucosa (Figure 1, B and C). Histological analysis by H&E
staining revealed that in addition to gross polyposis, there were
also areas of “flat” dysplastic change. The diameter of each area
of dysplasia per field of vision was measured by ocular micrometer. In the WT mouse colon, the average diameter of the dysplastic area was 2,040 μm compared with 1,075 μm in Epim–/– mice
(P < 0.01; Figure 1D). In addition, there was a decrease in the number of dysplastic lesions per field of vision in Epim–/– mice (14.8%;
n = 11) compared with WT mice (32.6%; n = 11; P = 0.041; Figure
1E). 1 of 11 Epim–/– mice had dysplasia in the ascending colon in
addition to the descending colon; 4 of 11 WT mice had dysplasia
in the ascending colon or cecum in addition to the descending
colon. There were no differences in the severity or grade of dys-
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plasia comparing WT with Epim–/– mice (Figure 1, F and G). In
addition, the pattern of β-catenin immunostaining was similar,
with nuclear accumulation only in areas of high-grade dysplasia
(Supplemental Figure 3). Cyclin D1 expression was also similar
(data not shown).
After brief exposure to DSS, Epim–/– mice exhibited a marked
increase in colonic crypt cell proliferation (19). AOM/DSS-treated
mice were injected with 5-BrdU 90 minutes prior to sacrifice, and
the labeling index was calculated in nondysplastic areas of the
cecum and the proximal and distal colon (Figure 2). There was
a significant increase in crypt cell proliferation in Epim–/– versus
WT mice in the cecum (Epim–/–, 14.64%; WT, 9.11%; P < 0.005) and
distal colon (Epim–/–, 16.64%; WT, 11.15%; P = 0.051), with a trend
toward an increase in the proximal colon. However, in dysplastic
areas of descending colon, there were no differences in cellular
proliferation per unit surface area (data not shown).
Areas of dysplastic and normal epithelium were evaluated for
apoptotic rate. There was no change in apoptosis in Epim–/– compared with WT mice, although effects on apoptosis at an earlier
stage in the disease process cannot be ruled out, since tissues were
analyzed at the end of the AOM/DSS treatment period.
Epimorphin deletion in myofibroblasts alters the morphology and growth
of cocultured Caco-2 cells. Epimorphin is abundantly expressed in
intestinal myofibroblasts, a major source of epimorphin in the

gut (19, 23). Immunohistochemical analysis of dysplastic colon
revealed that epimorphin was expressed in stroma surrounding
areas of dysplasia (Supplemental Figure 4).
To elucidate the mechanisms underlying the protection from epithelial dysplasia in Epim–/– mice, primary cultures of colonic myofibroblasts from Epim–/– and WT mice were established as described
previously (see Methods and ref. 24). Myofibroblast phenotype
was confirmed by immunocytochemistry showing robust expression of α-SMA and vimentin (Figure 3, A–D), minimal desmin
expression, and absence of expression of epithelial cytokeratin 19
(data not shown), consistent with a colonic myofibroblast phenotype (3) and similar to well-characterized small bowel myofibroblasts (24). Colonic myofibroblasts from WT mice also expressed
epimorphin and α-SMA, as determined by immunoblot (Figure
3E). As expected, myofibroblasts from Epim–/– mice did not express
epimorphin, but produced abundant α-SMA.
To examine the effects of myofibroblasts on the morphology,
proliferation, and differentiation of epithelium, we cocultured
myofibroblasts with Caco-2 cells (Figure 4). Caco-2 cells have been
routinely used in coculture models, as they adhere well to myofibroblasts, exhibit a differentiated enterocyte-like phenotype,
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and provide reproducible colony morphology (1, 18). Caco-2 cells
formed larger colonies on Epim–/– colon myofibroblasts compared
with Caco-2 colonies grown on WT myofibroblasts, which were
small and compact (Epim–/–, 128 μm colony diameter; WT, 76 μm
colony diameter; P < 0.05; Figure 4, A–C). Morphologic analysis
showed that Caco-2 cells seeded on WT myofibroblasts formed
multiple discrete, spherical, compact, and pseudostratified colonies. In contrast, Epim–/– myofibroblasts formed an epithelial
monolayer with only occasional small foci of pseudostratified
epithelium (Figure 4, D and E). To eliminate the possibility that
the morphologic differences were due to differences in adhesion
of Caco-2 cells to myofibroblasts, the number of adherent versus
floating cells was quantified from media of Epim–/– and WT myofibroblast–Caco-2 cocultures. No differences were noted at 24 or
72 hours after plating (data not shown).
Epimorphin deletion alters colonic myofibroblast expression of
paracrine factors including components of BMP, Hedgehog (Hh),
and Wnt signaling pathways. To further elucidate the molecular
basis for the differences in dysplasia in Epim–/– compared with WT
colon, gene expression profiling of Epim–/– versus WT colon myofibroblasts was performed using Agilent microarrays. The total
number of genes induced or inhibited greater than 2-fold as a consequence of epimorphin deletion was 2,552 and 3,327, respectively.
Because of the large number of genes that exhibited changes in
expression, we focused on confirming changes in expression in
gene families that encode stromal factors involved in the regulation of colonic epithelial proliferation. These included members of
the TGF-β superfamily including the BMP, Hh, and Wnt families
(Table 1). Changes in expression were confirmed by quantitative
real-time polymerase RT-PCR (qRT-PCR; Supplemental Methods;
n = 3 independent experiments). Additional key candidate genes
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for each signaling pathway were also evaluated by qRT-PCR. Of
the TGF-β superfamily members, BMP4 expression was increased
2.1-fold in Epim–/– compared with WT myofibroblasts. Marked
alterations in expression of BMP inhibitors was noted, including
Chordin-1 (68-fold increase), Follistatin (10-fold decrease), and
Noggin (64-fold decrease). Gremlin-2 expression was unchanged.
Analysis of the Hh signaling pathway showed that expression of
Hh family members including Hh-interacting protein (Hhip),
Cyclin BI, Patched-2, and Gli-3 were all decreased. In the Wnt family, expression of the Wnt inhibitors Dkk2, Dkk3, and Sfrp4 was
increased (2.9- to 6.2-fold); with a 1.5-fold decrease in Sfrp1.
Because the fold change in expression of the BMP inhibitors was
widely divergent in Epim–/– compared with WT myofibroblasts, we
examined the relative expression levels of BMP4 and BMP inhibitors in WT and Epim–/– myofibroblasts (Figure 5) to determine
which were the most abundantly expressed, and therefore might
be the most physiologically relevant. There was abundant BMP4,
Chordin-1, Follistatin, and Gremlin-2 mRNA expression in WT
and Epim–/– myofibroblasts, but significantly lower basal Noggin
expression compared with Chordin and BMP4 (P < 0.05; Figure 5).
The changes in expression were highest for Chordin (68-fold
increase) and Noggin (64-fold decrease; P < 0.05).
Epimorphin deletion results in increased production and secretion of
members of the BMP pathway. BMP4 and Chordin protein expression in cell lysate and media was quantified by ELISA (Supplemental Methods). Chordin expression was significantly increased
in Epim–/– compared with WT colon myofibroblasts (Figure 6A),
and there was a 10-fold increase in Chordin protein secretion from
Epim–/– versus WT colon myofibroblasts (Figure 6B; P < 0.05). In
addition, BMP4 protein expression was higher in Epim–/– myofibroblasts compared with WT (P < 0.05), and BMP4 secretion from
unstimulated Epim–/– myofibroblasts was 2-fold higher than WT,
although the difference was not statistically significant (Epim–/–,
79.8 pg/ml; WT, 39.5 pg/ml; P = 0.058; Figure 6, C and D).
To determine whether the effect of myofibroblast epimorphin
deletion on Caco-2 colony morphology is mediated by Chordin,
Epim–/– and WT myofibroblasts were cocultured with Caco-2
cells in the presence and absence of Chordin as described previously (25), and Caco-2 colony diameter was measured. Addition
of Chordin to WT cocultures increased Caco-2 colony size from
80 to 205 μm (P < 0.05; Figure 7). Observation by inverted phase
microscopy indicated that addition of Chordin reproduced the
phenotype of Caco-2 colonies cocultured with Epim–/– myofibro-
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Effects of epimorphin deletion on expression of selected members of the BMP, Hh, and Wnt pathways
Gene
BMP pathway
Bmp2
Bmp4
Chordin-1
Gremlin-2
Follistatin
Noggin
TGF-β2
TGF-β3
Smad5
Hh pathway
Hhip
CyclinB1
Patch-1
Patch-2
Gli-1
Gli-2
Gli-3
Wnt pathway
Fzd3
Sfrp1
Sfrp4
Dkk2
Dkk3

Fold change mRNA Epim–/– vs. WT
1.7
2.1A
68.3A
1.1
–9.7A
–64.1A
2.0A
1.0
1.0
–100.0A
–2.6A
–1.2
–1.9A
–1.3
1.4
–1.5A
1.0
–1.5A
6.2A
4.4A
2.9A
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R351$3OJOEFQFOEFOUFYQFSJNFOUTQFSGPSNFEPOQSJNBSZNZPGJ
CSPCMBTUDVMUVSFT"1

blasts, with a predominance of epithelial monolayers in the Chordin-treated cocultures (data not shown). As expected, the size of
Caco-2 colonies grown on Epim–/– myofibroblasts was unchanged
in the presence of additional exogenous Chordin (P = NS). These
results suggested that increased Chordin secretion was at least
partly responsible for the effect of epimorphin deletion on Caco-2
colony morphology.
To correlate these in vitro findings in vivo, we examined the
expression of BMP2 and BMP4 as well as the primary end target of BMP signaling, p-Smad1/5/8. Sections of dysplastic colon
from WT and Epim–/– myofibroblasts were incubated with an antiBMP2/4 antibody that detects BMP2 expression in colonic epithelial cells (26, 27) and BMP4 expression in stroma (27–29). BMP2
and BMP4 were expressed in WT and Epim–/– colon; in a subset of
Epim–/– colons, a small increase in epithelial and stromal expression was noted (Supplemental Figure 5).
To determine the net effect of epimorphin deletion on BMP
signaling in vivo, we examined p-Smad1/5/8 expression by
immunohistochemical analysis of AOM/DSS-treated Epim–/– and
WT colons (Figure 8). There was a marked decrease in p-Smad1/5/8
immunostaining in both normal, nondysplastic Epim–/– colon
(Figure 8, A and B) and dysplastic descending colon and rectal
epithelium (Figure 8, C–F) compared with AOM/DSS-treated WT
colon. These findings further suggest that epimorphin deletion in
myofibroblasts results in net BMP inhibition.
Epimorphin deletion blunts the colonic myofibroblast response to LPS.
Cytokine release plays a key role in tissue damage and the inflamThe Journal of Clinical Investigation

matory response in IBD (30). To determine cytokine expression
and secretory function in WT and Epim–/– myofibroblasts, cells
were treated with LPS for 24 hours to mimic the colitis-induced
inflammatory milieu. Expression of inflammatory mediators
upregulated in acute DSS colitis (TNF-α, IL-6, IFN-γ) with key
roles in colitis-associated colon carcinogenesis (31, 32) was evaluated by qRT-PCR. In response to LPS, IL-6 expression increased in
WT and Epim–/– myofibroblasts compared with unstimulated myofibroblasts (P < 0.05; Figure 9A). After exposure to LPS, IL-6 mRNA
expression in Epim–/– myofibroblasts was decreased compared with
WT cells. However, IL-6 protein expression was increased in LPSstimulated Epim–/– myofibroblasts compared with unstimulated
Epim–/– cells, at levels exceeding those of LPS-stimulated WT cells
(Figure 9B). Despite abundant protein expression, Epim–/– myofibroblasts did not secrete IL-6 into the media, unlike WT cells
(Figure 9C). The profound decrease in IL-6 secretion in response
to LPS was not due to absence or downregulation of TLR expression. Myofibroblasts responded to LPS by increasing IL-6 mRNA
and protein in both Epim–/– and WT myofibroblasts. In addition,
TLR4 mRNA was expressed in myofibroblasts, and TLR4 mRNA
levels were increased greater than 2-fold in Epim–/– compared with
WT cells (data not shown).
IFN-γ expression was very low in both Epim–/– and WT colon
myofibroblasts and was not altered in response to LPS (data not
shown). TNF-α mRNA expression in WT and Epim–/– myofibroblasts was barely detectable, and was more than 10-fold lower than
IL-6 expression. TNF-α protein was not detected in cell lysates, nor
was it detectable in secreted form upon LPS stimulation in either
WT or Epim–/– myofibroblasts (data not shown).
To correlate these in vitro findings in vivo, we performed
immunohistochemical analysis of IL-6 expression in AOM/DSStreated Epim–/– and WT colon (Figure 10). IL-6 expression in WT
dysplastic colon (Figure 10A) and in normal nondysplastic areas
(Figure 10, C and E) was strongest in the stroma, with weak but
detectable expression in the epithelium (consistent with previously reported IL-6 expression patterns; ref. 31). In contrast,
in dysplastic (Figure 10B) and adjacent nondysplastic colonic
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mucosa of AOM/DSS-treated Epim–/– mice (Figure 10, D and
F), stromal IL-6 expression was markedly diminished compared
with WT. Despite the decrease in stromal expression, pericryptal
cells at the base of the crypts in Epim–/– mice showed expression
of IL-6 (Figure 10F), consistent with their ability to synthesize
but not secrete IL-6 (Figure 9C).
Serum levels of IL-6 and TNF-α were measured by ELISA in
AOM/DSS-treated Epim–/– and WT mice, and no significant differences were found (data not shown, n = 4 mice per group). Serum
concentrations were measured in individual mice, and there was
no correlation between tumor burden and serum cytokine levels.
These results suggested that epimorphin deletion may not block
IL-6 secretion from other cell types, e.g., from myeloid cells such
as macrophages (which also express epimorphin; ref. 33) and dendritic cells, the 2 major cellular sources of elevated IL-6 levels in
chronic inflammation–associated carcinogenesis (31). To evaluate
whether epimorphin deletion inhibits IL-6 secretion from other
cell types, we examined the effect of epimorphin deletion on resident peritoneal macrophages, which are reflective of the intestinal environment and well-described in the colitis model (34, 35),
and on bone marrow–derived dendritic cells. Resident peritoneal

macrophages were cultured as described previously (35, 36), and
supernatants were collected for IL-6 assay. Epimorphin deletion
significantly diminished, but did not completely block, secretion
of IL-6 from resident peritoneal macrophages (689 pg/ml to 272
pg/ml; P < 0.05; Supplemental Figure 6). We then evaluated the
effect of epimorphin deletion on cultured bone marrow–derived
dendritic cells. Because this population does not secrete measurable IL-6 at baseline, cells were treated with LPS for 24 hours,
and IL-6 secretion was quantified. Epimorphin deletion did not
change IL-6 secretion in response to LPS, which increased in both
WT and Epim–/– bone marrow–derived dendritic cells (data not
shown). These data suggest that epimorphin deletion reduces local
IL-6 production from myofibroblasts, and, to a lesser extent, from
macrophages, which are uniquely located adjacent to epithelium
and the stem cell niche (9).
To rule out the possibility that compensatory changes in other
syntaxins resulted in the altered secretory patterns in Epim–/– myofibroblasts, we examined expression of syntaxins 1a, 3, and 4, which
have the highest percentage homology with epimorphin, and syntaxins 5 and 6, which are also expressed in myofibroblasts (ref.
37 and Supplemental Figure 7). No differences in mRNA expression were noted except for absence of epimorphin, as expected,
in Epim–/– myofibroblasts.
To further evaluate the altered secretory patterns in Epim–/– myofibroblasts, electron microscopy was performed to analyze the
ultrastructural morphology of Epim–/– and WT myofibroblasts
(Figure 11). Parameters included nuclear to cytoplasmic ratios,
nuclear membrane regularity and/or roundness, cytoplasmic
membrane complexity, length and state of distention of the rough
endoplasmic reticulum (RER), and mitochondria. There was an
increase in long parallel stacks of RER in Epim–/– cells (Figure 11,
A and B). In addition, the short stacks of RER were significantly
more dilated in Epim–/– myofibroblasts (Figure 11C). Dilation of
RER is associated with increased accumulation of protein (38, 39),
consistent with our findings that synthesis and secretion of IL-6
and a subset of BMP inhibitors were markedly altered by epimorphin deletion. There were no differences in the other morphologic
parameters. Because these morphological findings were suggestive
of ER stress (40), mRNA expression of the ER stress markers Xbp-1
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of the decreased expression of several Hh targets in Epim–/– myofibroblasts, myofibroblasts were incubated with recombinant
sonic hedgehog (Shh) to determine whether there is also a blunted
response to Hh signals. (Ihh and Shh are identical with respect to
receptor binding and target gene activation; ref. 44). Expression
of Hhip increased 3.5-fold (P < 0.05), Gli-1 increased 6.13-fold
(P < 0.05), and Ptc-1 increased 2.8-fold (P = 0.07) in WT myofibroblasts treated with Shh. Epim–/– colon myofibroblasts treated
with Shh had increased expression of Gli1 only (2.3-fold; P < 0.01);
however, absolute levels of Gli1 remained 3.7-fold less than in WT
(P < 0.005). Treatment with Shh did not induce Hhip and Ptc-1
expression in Epim–/– myofibroblasts (Figure 12).
%JTDVTTJPO
Deletion of epimorphin reduced the incidence and extent of dysplasia in the AOM/DSS model of inflammation-induced colon
carcinogenesis. This protection from dysplasia was associated with
increased crypt cell proliferation in adjacent nondysplastic Epim–/–
epithelium. Epimorphin deletion also affected myofibroblast-epithelial interactions in vitro: WT myofibroblasts cocultured with
epithelial Caco-2 cells exhibited small, compact Caco-2 colony
morphology with a pseudostratified epithelium; in contrast, Caco2 cells cocultured with Epim–/– myofibroblasts showed increased
colony diameter and epithelial monolayer formation. Epimorphin
deletion induced marked changes in expression and secretion of
a subset of BMP inhibitors, resulting in a net decrease in colonic
BMP signaling, as indicated by reduced p-Smad1/5/8 expression.
'JHVSF
The importance of BMP inhibition was further established by
mm
Q4NBEFYQSFTTJPOJO&QJN BOE85DPMPOBGUFS"0.%44USFBU
NFOU4FDUJPOTPGDPMPOXFSFJODVCBUFEXJUIQPMZDMPOBMSBCCJUBOUJm showing that addition of Chordin to WT myofibroblast–Caco-2
Q4NBE EJMVUJPO GPMMPXFECZCJPUJOZMBUFEHPBUBOUJSBCCJU epithelial cocultures recapitulated the growth and morphology of
*H( TUSFQUBWJEJOmIPSTFSBEJTIQFSPYJEBTF BOEEJBNJOPCFO[JEJOF3FQ Caco-2 colonies cocultured with Epim–/– myofibroblasts. EpimorSFTFOUBUJWFTFDUJPOTPGOPOEZTQMBTUJD "BOE# BOEEZTQMBTUJDDPMPOT phin deletion also resulted in a profound decrease in LPS-stimulat$m' PG85 " $ & BOE&QJNmm # % ' NJDFBSFTIPXO "BOE#  ed myofibroblast secretion of the proinflammatory cytokine IL-6,
%FDSFBTFEPSBCTFOUCSPXOOVDMFBSTUBJOJOHXBTOPUFEJO&QJNmmDPMPO with reduced IL-6 expression in AOM/DSS-treated Epim–/– colon.
# XIJUFBSSPXT DPNQBSFEXJUIIPNPHFOFPVTCSPXOOVDMFBSTUBJO Electron microscopy of Epim–/– myofibroblasts depicted morphoJO85 "  $BOE% Q4NBEFYQSFTTJPOXBTIFUFSPHFOFPVTJO
logic changes in the RER consistent with the marked alteration in
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Our data suggest that the mechanisms by which epimorphin
&BOE' %ZTQMBTJBGSPN85EFTDFOEJOHDPMPO & TIPXFEMJHIUCSPXO
OVDMFBSTUBJO XIFSFBT&QJNmmEZTQMBTUJDEFTDFOEJOHDPMPO ' TIPXFE deletion results in protection from dysplasia are complex, and
BNBSLFEEFDSFBTFJOOVDMFBSTUBJOJOHDPNQBSFEXJUI850SJHJOBM likely include enhanced epithelial repair resulting from episodic
NBHOJGJDBUJPO ¤ " # & BOE' ¤ $BOE% 
increased crypt cell proliferation as well as reduced epithelial cell
damage caused by decreased inflammation. These changes appear
to be mediated, at least in part, by inhibition of BMP and IL-6 sigunsliced (Xbp-1u), Xbp-1 sliced (Xbp-1s), Atf4, and Grp78 were naling. In addition, because IL-6 has been postulated to regulate
evaluated. Epimorphin deletion increased Xbp-1u, Xbp-1s, and tumor stem cell proliferation, epimorphin deletion may also exert
Atf4 (1.9-, 2.7-, and 1.7-fold, respectively; P < 0.05), whereas Grp78 effects on tumorigenesis.
BMP, Wnt, Hh, and Notch signaling interplay in the stem cell
remained unchanged (Figure 11D).
Epimorphin deletion alters Hh signaling. Hh ligands produced by gut niche to regulate intestinal crypt cell proliferation (29, 45–48). Our
epithelial cells act on receptors located on mesenchymal cells to acti- data showed that expression and secretion of a subset of soluble
vate downstream stromal target genes (41, 42). Hhip, Gli-1, Gli-2, mesenchymal BMP pathway components were regulated by epiGli-3, Patched 1 (Ptc-1), and Ptc-2 are stromal targets of Hh signals, morphin deletion, resulting in decreased BMP signaling in vivo
and Hh signaling activity is best reflected by measuring Gli1, Ptc-1, (Figure 8). BMPs and BMP inhibitors originate from the stroma
and Hhip mRNA levels (42, 43). Several Hh targets are expressed by and act on adjacent epithelium (27–29). Expression of these inhibboth WT and Epim–/– colon myofibroblasts, and mRNA levels of a itors is highest toward the base of the crypts, adjacent to the stem
subset of these were decreased in Epim–/– compared with WT myo- cell niche (49). BMPs inhibit crypt cell proliferation, presumably
fibroblasts (Table 1), including a marked decrease in expression of via effects on Wnt–β-catenin signaling mediated by the PTENHhip, which inhibits Hh signaling and reflects pathway signaling PI3K-Akt pathway (29), although the precise mechanisms are still
activity. Because Hh ligands are expressed only in epithelial cells, being clarified (50). A balance between BMPs and BMP inhibitors
cultured myofibroblasts presumably do not receive Hh signals, and is thought to play a role in maintaining normal basal levels of
signaling activity is low. To determine the physiologic significance crypt cell proliferation (49).
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The net effect of epimorphin deletion is inhibition of BMP signaling in the epithelium, as indicated by decreased p-Smad1/5/8
expression (Figure 8). This would be expected to lead to an increase
in crypt cell proliferation, as shown in Figure 2. Although expression of a subset of BMP inhibitors is decreased in Epim–/– myofibroblasts (Figure 5), and BMP4 expression and secretion were increased
(Figures 5 and 6), it is likely that Chordin’s inhibitory actions are
locally dominant in the crypt due to its 10-fold increased secretion.
Chordin’s key role is further supported by its effects in Epim–/– myofibroblast cocultures (Figure 7). We postulate that in Epim–/– mice,
BMP inhibition stimulates enhanced crypt cell proliferation early
in the course of AOM/DSS-induced disease, resulting in enhanced
epithelial repair and decreased tumorigenesis.
Our model appears to result in partial, but not complete, BMP
inhibition, as indicated by persistent, albeit reduced, p-Smad1/5/8
expression. Complete BMP inhibition might be expected to result
in a tumorigenic phenotype, as in mice that have a nonfunctional
BMP receptor BMPR1A (51), or in Noggin-overexpressing mice
(27, 28), both of which result in a juvenile polyposis phenotype
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and markedly enhanced epithelial proliferation rate. Although
BMP inhibition is likely to result in unopposed Wnt signaling,
epimorphin deletion resulted in decreased dysplasia. We postulate
that in our model, BMP inhibition results in enhanced epithelial
repair and that this, in conjunction with markedly reduced IL-6
secretion, leads to partial protection from dysplasia.
Epimorphin deletion completely blocked IL-6 secretion by myofibroblasts, and in vivo analysis of IL-6 expression in Epim–/– and
WT dysplasia in the AOM/DSS model demonstrates that epimorphin deletion results in diminished stromal IL-6 expression. We
also showed that epimorphin deletion reduced IL-6 secretion by
peritoneal macrophages, but not by bone marrow–derived dendritic cells. Reduced stromal IL-6 likely results in decreased epithelial cell damage (38). In addition, IL-6 is active in the tumor
stem cell niche (52); reduced secretion may also result in decreased
proliferation of dysplastic premalignant cells, thus suggesting a
direct effect on tumorigenesis (31, 52). Our data are consistent
with studies from other laboratories (31, 32, 53) that have shown
that IL-6 plays a key role in the pathogenesis of colitis-associated
carcinogenesis. The pleiomorphic effects of epimorphin deletion
on secretion of multiple factors, particularly IL-6, likely explains
why the observed increase in colonic crypt cell proliferation did
not result in larger tumors, as in other genetic models of chronic
inflammation–associated carcinogenesis, such as the SOCS3-null
mouse (32). It is likely that the end result of epimorphin deletion
is a change in secretion of soluble factors that overall has beneficial
effects, resulting in reduced dysplasia.
Wnt signaling is critically important in regulating normal crypt
cell proliferation and is dysregulated in colon carcinogenesis. In
colitis-associated neoplasia, Apc mutations are much less common compared with sporadic colon cancer and occur later in the
disease (20, 54). Both epithelial and mesenchymal cells express
Wnts (55), but the precise sources and regulation of Wnt secretion are still being clarified. Expression of several Wnt inhibitors
was upregulated in Epim–/– myofibroblasts. However, epimorphin
deletion did not alter expression of nuclear β-catenin or cyclin D1
in dysplastic tumors and did not affect the proportion of low- and
high-grade dysplastic lesions. The significance of the change in
expression of Wnt inhibitors is unclear from our studies, which
evaluated Wnt target gene expression at an advanced stage of the
disease process. Following Apc mutation, nuclear β-catenin signaling becomes dysregulated, and changes in Wnt ligand expression may no longer affect downstream signaling; however, it is
possible that enhanced secretion of Wnt inhibitors earlier in the
disease course, prior to Apc mutation, may diminish proliferation
of dysplastic epithelium.
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We have shown that the function of Epim–/– myofibroblasts was
profoundly altered, resulting in marked changes in myofibroblast
secretory function. These effects are likely due to epimorphin’s role
as a syntaxin. These membrane-bound proteins have an intracellular,
cytoplasmic orientation and are involved in trafficking of secretory
vesicles. Our data suggest epimorphin deletion results in marked
and specific alteration in secretory function, indicating that particular syntaxins may regulate the release of a subset of secreted proteins. Altered secretory function was not caused by compensatory
changes in expression of other syntaxins in Epim–/– myofibroblasts
(Supplemental Figure 7) or in Epim–/– intestine (19). IL-6 secretion
from WT myofibroblasts was stimulated in response to LPS, but
completely blocked in Epim–/– myofibroblasts. This occurred despite
an increase in IL-6 mRNA and protein production in both Epim–/–
and WT cells, suggesting a profound alteration in the IL-6 secretory
process. In contrast, Chordin and BMP4 secretion were increased.
The consequences of epimorphin deletion may be pathway dependent, and appear to differ in stimulated versus constitutive secretory
processes. In the mammary gland, epimorphin is itself secreted (12,
17). However, immunoblot of concentrated media from WT myofibroblasts showed virtually no secretion of epimorphin, despite
abundant cellular protein expression (data not shown).
Epim–/– myofibroblasts showed decreased expression of Hh target
genes after exposure to Hh ligands compared with WT myofibroblasts. These data suggest that deletion of epimorphin also affects
the myofibroblast’s ability to respond to soluble factors that signal
to the mesenchyme. Unlike in other epithelial cancers, in which
activated Hh signaling results in increased proliferation, active
Hh signaling has been shown to inhibit crypt cell proliferation in
the colon and small bowel (46). It is possible that this change in
responsiveness to Hh signals contributes to enhanced crypt cell
proliferation in the Epim–/– mice, but further studies are required
to interrogate this complex pathway.
The Journal of Clinical Investigation

Overall, our data suggest that protection from dysplasia is likely
mediated, at least in part, by changes in the function and secretory profile of intestinal subepithelial myofibroblasts. Our results
suggest potentially novel pathogenetic mechanisms of inflammation-induced colonic dysplasia, which may be relevant for patients
with IBD. Our data suggest that the stromal environment, including the myofibroblast, plays a significant role in inflammationinduced dysplasia. Although stromal interactions with the epithelium have been suggested to play a pathogenic role in colorectal
carcinogenesis and inflammation-induced colon cancer, the epimorphin deletion mouse model is unique because myofibroblast
secretory function has been altered. MSCs have been increasingly
recognized to play an important role in wound repair in epithelial
tissues (7, 8, 56). Whether the MSC or a more differentiated progeny cell is responsible for cross-talk within the stem cell niche is
unclear. Our studies suggest that the myofibroblast may be one of
the MSC progeny that is active within the stem cell niche. These
studies also suggest what we believe to be a novel therapeutic target for treatment of IBD and prevention of colorectal cancer, since
modifying myofibroblast function appears to affect epithelial cell
proliferation and the incidence and severity of dysplasia.
In summary, epimorphin deletion showed beneficial effects in 2
colitis/injury models, the acute DSS-induced colitis model (19) and
the AOM/DSS model of colitis-associated carcinogenesis, which
suggests that modulating the function of this myofibroblast protein may have a therapeutic effect in the appropriate clinical setting. Our results confirm the complexity of mesenchymal-epithelial
interactions and suggest a role for myofibroblasts in colonic injury,
repair, and carcinogenesis. We have shown that, in the AOM/DSS
model, an intervention resulting in increased crypt cell proliferation may still have beneficial effects even in the long term. Thus,
therapies that increase epithelial repair and crypt cell proliferation
while reducing inflammatory damage may have a place in the IBD/
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chronic inflammatory disorder armamentarium. Since epimorphin
is widely expressed in the stroma of other epithelial tissues, these
data may have relevance to other inflammation-induced epithelial
cancers, such as those in pancreas, esophagus, and skin.
.FUIPET
Animals. Epim–/– mice, with a global deletion of epimorphin, were generated
as described previously (19), and C57BL/6J WT littermates or C57BL/6J
mice purchased from Jackson Laboratory were used as controls. Mice purchased from Jackson Laboratory were acclimated to the animal facility for
3.5 weeks. Mice were housed in a 12-hour light/dark cycle with free access
to food and water. Mice were fed a standard rodent chow diet (PicoLab 20;
Purina). Age-matched 8- to 12-week-old Epim–/– mice and their WT littermates were used in all experiments. All animal experimentation was
approved by the Animal Studies Committee of Washington University
School of Medicine.
AOM/DSS model for colitis-induced carcinogenesis. Congenic Epim–/– mice
(on a C57BL/6J background; n = 17) and WT C57BL/6J mice (n = 22) were
injected with AOM (13.5 mg/kg; Sigma-Aldrich) on day 0 (Supplemental
Figure 1). On day 5, 3 cycles of DSS (2.5%, 3%, 3% in drinking water; 5 days/
cycle) were initiated, each separated by 15 days of vehicle control (water).
This regimen was chosen based on pilot studies showing that a previously
published lower-dose regimen (21, 22) of AOM (12.5 mg/kg) followed by
3 cycles of 2.5%, 2.5%, 2% DSS in drinking water did not result in dysplasia
in our mice. Mice were sacrificed 20 days after completion of the third DSS
cycle, and tissues were placed into 10% formalin for histology. The presence
and grade of dysplasia (low versus high grade) was evaluated as described
previously (57). Apoptosis was evaluated by routine histologic methods on
H&E-stained tissue (58). Serum was collected, and ELISA was performed
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per the manufacturers’ instructions for TNF-α, IFN-γ (BD Biosciences),
and IL-6 (eBioscience).
Crypt cell proliferation. At 90 minutes prior to sacrifice, mice were injected
intraperitoneally with 5-BrdU (8 g/l) and 5-fluorodeoxyuridine (0.8 g/l),
total dose 120 mg/kg. 5-BrdU was detected with a monoclonal anti-BrdU
antibody (Zymed Laboratories Inc.), and crypt cell proliferation was
assessed as described previously (19). To correct for differences in crypt
depth, labeling index was calculated as the number of 5-BrdU–positive cells
per total crypt cell number (19). Crypt cell proliferation indices were also
quantified separately in areas adjacent to ulcerations and were compared
in WT and Epim–/– mice.
Quantification of polyposis and dysplasia. Grossly visible polyps were counted
and diameters measured. Tumor area and total colon area were measured
using Metaview software, and the percentage of tumor area per total colon
area was calculated. Colons were divided into cecum, proximal, and distal
colon, sectioned, and stained with H&E. The entire colon was analyzed for
dysplasia by light microscopy (magnification, ×40; the presence of dysplasia
was confirmed under higher-power magnification, ×100). The number of
fields of vision was counted, and the percentage with dysplasia was calculated as the number of dysplastic segments per fields of vision. The diameter
of dysplastic lesions was measured with Axiovision software (Zeiss).
Generation of Epim–/– and WT colon myofibroblast primary cultures. 3 Epim–/– and
3 WT colon myofibroblast primary cultures were established as previously
described (24, 59) from WT and Epim–/– 7- to 9-day-old mice. Briefly, colon
from cecum to rectum was placed in HBSS (Invitrogen), washed briefly, transferred into fresh HBSS, and minced into 2- to 3-mm pieces. Tissue was washed
8 times with HBSS by vigorous shaking, allowing for fragments of colon to
sediment out; incubated with 300 U/ml collagenase XI (Sigma-Aldrich) and
0.1 mg/ml dispase (Gibco, Invitrogen) for 25 minutes at room temperature
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1śWFSTVT85 1WFSTVTVOUSFBUFE&QJNmm f1
WFSTVT4IIUSFBUFE85

with gentle shaking; and then centrifuged at low speed (4 g) for 10 minutes.
Supernatant was discarded. The pellet, containing intact organoids with
attached myofibroblasts, was transferred to a 1.7-ml tube, minced with scissors, and washed 5 times in DMEM (Gibco, Invitrogen) with 2% sorbitol
(Sigma-Aldrich) to eliminate isolated cells and then centrifuged 1–2 minutes at low speed. Cells were seeded in 6-well plates and cultured in DMEM
with 10% FBS (US Biotechnologies Inc.), insulin (Sigma-Aldrich), transferrin
(Roche), and gentamicin (Calbiochem EMD Chemicals), all 10 μg/ml, as well
as 2 ng/ml EGF (Sigma-Aldrich). After 4 days, mesenchyme-derived cells were
passaged to T25 flasks using 0.05% trypsin in 0.53 mM EDTA (Cellgro, Mediatech). Under these conditions, epithelial cells do not survive.
Caco-2 cell culture. The Caco-2 human colon cancer epithelial cell line was
grown as described previously (18). Cell lines were passaged every 4–7 days.
RNA analysis by qRT-PCR. qRT-PCR was performed as described previously (19); see Supplemental Methods for details. SuperScript II Reverse
Transcriptase (Invitrogen) was used for synthesis of cDNA. Real-time
RT-PCR analysis using SYBR green PCR Master Mix (Applied Biosystems)
was performed in an ABI Prism 7700 sequence detection system (Applied
Biosystems). Primer sequences are listed in Supplemental Table 1.
Gene expression profiling. To determine the identity of putative myofibroblast morphogens, total RNA was prepared from Epim–/– and WT colon
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myofibroblasts between passages 6–9, cultured for 1 week. Total RNA
from which probes were generated was prepared from a pool of 3 myofibroblast isolates for each. Probes were hybridized to Agilent microarrays
as per the Genomics Core of the Digestive Diseases Research Core Center
(DDRCC, Washington University School of Medicine). The data set was
searched to identify putative epimorphin targets that exhibited greater
than 2-fold increase or less than 0.5-fold decrease in expression between
Epim–/– and WT colon myofibroblasts (GenePix 6.0 acquisition and analysis software; ref. 18), focusing on members of the BMP/TGF-β, Wnt, and
Hh families. Changes in expression of selected genes on microarray were
all confirmed by qRT-PCR.
Immunocytochemistry. Primary cultures of colonic myofibroblasts and
Caco-2 cell lines were grown on chamber slides (Nalge Nunc International)
and fixed in 10% formalin (room temperature) for 10 minutes, permeabilized with ice-cold methanol, and stored at –20°C. After incubation in
blocking solution containing 5% BSA and 3% milk in Tris buffer (20 mM
Tris HCl; 150 mM NaCl, pH 7.4; and 0.05% Tween 30) for 60 minutes, slides
were incubated with primary antibody diluted in blocking solution at 4°C
overnight. To confirm the myofibroblast phenotype, rabbit polyclonal
antibodies to α-SMA (ab5694, 1:200 dilution; Abcam); desmin (D8281,
1:100 dilution; Sigma-Aldrich); cytokeratin 18 (1:100 dilution; Millipore
Corp.); vimentin (V4630, 1:100 dilution; Sigma-Aldrich); were used. Secondary antibody labeled with fluorescein or Cy3 diluted in blocking solution was applied for 1 hour at room temperature. Cells were mounted in
Vectashield Mounting Medium with DAPI and examined under a fluorescence microscope (Axioshop 2; Carl Zeiss Jena GmbH).
Immunohistochemical analyses. Epimorphin expression in WT colon was
analyzed as described previously (19) using a polyclonal rabbit anti–syntaxin 2 antibody (1:500 dilution; Synaptic Systems) that was purified to
remove cross-reactivity with other syntaxins, by preabsorption with total
protein isolated from Epim–/– mouse intestine (1 μg antibody incubated
with 50 μg protein). Epitope retrieval was with the Nuclear DECLOAKER
reagent (BIOCARE) in a decloaking chamber. Primary antibody was
applied overnight at 4°C. Antigen antibody complexes were detected with
biotinylated goat anti-rabbit IgG (1:2,000 dilution) and donkey anti-goat
IgG (1:2,000 dilution; Jackson ImmunoResearch Laboratories Inc.) and
streptavidin–horseradish peroxidase with tyramide amplification, then
developed in diaminobenzidine.
BMP2/BMP4 expression was detected as described previously (19) using
a polyclonal goat anti-human BMP2/4 antibody (1:300 dilution; R&D Systems) that cross-reacts with mouse, and antigen retrieval with citraconic anhydride. p-Smad1/5/8, nuclear β-catenin, and cyclin D1 expression was detected using a polyclonal rabbit anti–p-Smad1/5/8 (1:100 dilution; Millipore),
polyclonal rabbit anti–β-catenin antibody (1:600 dilution; BD Transduction
Laboratories), and rabbit anti–cyclin D1 antibodies (1:200; Santa Cruz).
Antigen retrieval for p-Smad1/5/8, nuclear β-catenin, and cyclin D1
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was performed with Diva Decloaker reagent (BIOCARE). Antigen-antibody
complexes were detected with biotinylated goat anti-rabbit IgG (1:500 dilution; PerkinElmer), streptavidin–horseradish peroxidase, and diaminobenzidine. IL-6 expression was detected using a goat anti-recombinant mouse IL-6
antibody (1:50 dilution; R&D systems) followed by a biotinylated donkey
anti-goat antibody (1:500 dilution; Jackson ImmunoResearch Laboratories),
streptavidin–horseradish peroxidase, and diaminobenzidine.
LPS stimulation of myofibroblasts. Epim–/– and WT colon myofibroblasts
were seeded at a density of 2 × 105 cells per well in 6-well plates and grown
to 85% confluence. Cultured myofibroblasts were incubated with LPS (2.5,
5, and 10 μg/ml in serum-free media) for 6 hours (List Biological Laboratories Inc.). Based on this dose response, cells were incubated for 24 hours
with LPS (5 μg/ml). Supernatant was collected for ELISA. Cells were harvested for RNA and protein for qRT-PCR and ELISA as described above
and in Supplemental Methods. qRT-PCR data was expressed as fold induction relative to untreated samples.
Resident peritoneal macrophage isolation. Resident peritoneal macrophages
were isolated by flushing the peritoneal cavity with cold PBS as described previously (35, 36, 60). Cells were counted for viability by trypan blue exclusion;
plated (5 × 105 cells/well) in a 96-well plate in RPMI 1640 media (BioWhittaker) with 2 mM L-glutamine (Life Technologies), 10 mM HEPES, 1 mM sodium
pyruvate (BioWhittaker), 50 U/ml penicillin and 50 mg/ml streptomycin (Life
Technologies), 50 mM 2-ME (Fisher Scientific), and 10% FCS (HyClone); and
cultured at 37°C in 5% CO2. After 24 hours, supernatants were collected for
determination of IL-6 secretion by ELISA (Supplemental Methods).
Generation of bone marrow–derived dendritic cells. Dendritic cells were generated from mouse bone marrow progenitors as described previously (61).
Bone marrow cells were harvested from femurs of Epim–/– and WT mice
(n = 2) and cultured in 6-well plates with GM-CSF (10 ng/ml) and IL-4
(0.3 ng/ml) in RPMI 1640 media supplemented as described above. Media
containing GM-CSF and IL-4 was replaced on days 3 and 6 of culture. On
day 7, cells were harvested; a portion was evaluated by flow cytometry to
confirm the generation of dendritic cells. Remaining dendritic cells were
plated in 96-well plates (5 × 105 cells/well) and treated with LPS (1 mg/ml)
for 24 hours. Cells were harvested for RNA isolation, and supernatant was
collected for evaluation of IL-6 secretion by ELISA.
SHH signaling in myofibroblasts. Epim–/– and WT colon myofibroblasts were
seeded at a density of 2 × 105 cells/well in 6-well plates and grown to 85%
confluence. Cells were incubated with recombinant mouse SHH aminoterminal peptide (0.9 μg/ml; R&D Systems) diluted in serum-free media; after
24 hours, cells were harvested, and RNA was isolated for qRT-PCR.
Myofibroblast–Caco-2 coculture experiments. Epim–/– and WT colon myofibroblasts were plated as previously described (ref. 18; 1 × 106 cells/well)
and cultured for 3 days in 6-well plates (Costar Corning Inc). Caco-2 cells
were seeded on top of subconfluent layers of myofibroblast cells (3 × 105
cells/well). To assess adherence of the Caco-2 cells to the Epim–/– and WT
myofibroblasts, media was collected at 24 and 72 hours after plating, and
cells were counted; no differences in cell adherence were found (n = 2 experiments). Cocultures were examined daily by inverted phase microscopy,
and photomicrographs were taken on day 4 after plating. To quantify dif1. Kedinger M, Duluc I, Fritsch C, Lorentz O, Plateroti M, Freund JN. Intestinal epithelial-mesenchymal
cell interactions. Ann N Y Acad Sci. 1998;859:1–17.
2. Coussens LM, Werb Z. Inflammation and cancer.
Nature. 2002;420(6917):860–867.
3. Powell DW, Mifflin RC, Valentich JD, Crowe
SE, Saada JI, West AB. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol.
1999;277(2 pt 1):C183–C201.
4. Hayward SW. Approaches to modeling stromal-epithelial interactions. J Urol. 2002;168(3):1165–1172.
5. Kedinger M, Simon-Assmann PM, Lacroix B, Marxer


ferences in Caco-2 colony size and assess morphology, photomicrographs
were taken from 4 quadrants per well. The diameter of each Caco-2 colony
was measured using Axiovision software (Zeiss). After 7 days, cocultures
were fixed in paraformaldehyde and processed for histology.
Chordin (2 μg/ml; R&D Systems) was added to media immediately after
Caco-2 cells were seeded and again on day 3 of coculture. Morphology and
colony diameters were measured on day 4 as described above.
Electron microscopic analysis. Epim–/– and WT colon myofibroblasts were
grown to confluence in T25 flasks (n = 2 independent experiments),
harvested with trypsin/EDTA, fixed with 2.5% glutaraldehyde, and processed for electron microscopy by the Electron Microscopy Core, Washington University School of Medicine. A total of 20 Epim–/– cells and 15
WT cells were observed at ×3,000 and ×4,400 magnification, and images
were obtained from several quadrants of each section. Nuclear/cytoplasmic
ratio, nuclear membrane regularity and roundness, cytoplasmic membrane
complexity, length of the rough ER, and mitochondria were evaluated in
a semiquantitative manner, using magnification prints and a transparent
0.2-cm grid. A total of 48 prints were scored. The state of dilation of the
short stacks of rough ER was assessed for 16 Epim–/– and 11 WT cells. Each
cell was divided into 4 quadrants. The width of 3–5 stacks of rough ER in
each quadrant was measured using the transparent grid, and the average
width of rough ER was calculated for each quadrant. Images were independently reviewed by a pathologist blinded to the genotype.
Statistics. Data comparing Epim–/– and WT mice are presented as mean ±
SEM, and significance was analyzed by 2-tailed Student’s t test (Microsoft
Excel; Microsoft). P values less than or equal to 0.05 were considered significant. Mortality rates were compared in Epim–/– and WT mice using the
Fisher exact probability test (Vasserstats).
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